共 50 条
[1]
MITOMYCIN-C, 5-FLUOROURACIL AND CYTOSINE-ARABINOSIDE (MFC) IN GASTROINTESTINAL CANCER
[J].
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH,
1974, 15 (MAR)
:178-178
[2]
CHEMOTHERAPY FOR COLORECTAL CANCER WITH A COMBINATION OF 5-FLUOROURACIL, MITOMYCIN-C, ADRIAMYCIN, AND CYTOSINE-ARABINOSIDE - PILOT-STUDY
[J].
CANCER TREATMENT REPORTS,
1978, 62 (10)
:1557-1559
[6]
COMBINATION THERAPY WITH MITOMYCIN-C, 5-FLUOROURACIL, AND CYTOSINE-ARABINOSIDE IN P815 ASCITES AND SOLID MOUSE NEOPLASMS
[J].
CANCER TREATMENT REPORTS,
1976, 60 (09)
:1399-1400
[8]
ADRIAMYCIN (A), 5-FLUOROURACIL + MITOMYCIN-C + CYTOSINE-ARABINOSIDE (F M C), AND 5-FLUOROURACIL + ADRIAMYCIN + METHYL CCNU (F A ME) IN ADVANCED GASTRIC CARCINOMA
[J].
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH,
1978, 19 (MAR)
:343-343
[9]
COMBINATION 5-FLUOROURACIL, ADRIAMYCIN, MITOMYCIN-C, AND METHYL CCNU (FAMME) CHEMOTHERAPY FOR ADVANCED GASTROINTESTINAL CANCER
[J].
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH,
1981, 22 (MAR)
:264-264
[10]
COMBINATION THERAPY WITH MITOMYCIN-C (NSC-26980), 5-FLUOROURACIL (NSC-19893), AND CYTOSINE-ARABINOSIDE (NSC-63878) FOR ADVANCED CANCER IN MAN
[J].
CANCER CHEMOTHERAPY REPORTS PART 1,
1972, 56 (03)
:373-+